HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 202 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $513,246 | -86.7% | 14,585 | -87.7% | 0.02% | -87.2% |
| Q1 2023 | $3,857,042 | +113.9% | 118,133 | +261.0% | 0.12% | +112.7% |
| Q4 2022 | $1,803,312 | +137.0% | 32,728 | +90.3% | 0.06% | +83.3% |
| Q3 2022 | $761,000 | +154.5% | 17,199 | +178.9% | 0.03% | +200.0% |
| Q1 2022 | $299,000 | – | 6,166 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $496,847,000 | 95.45% |
| Vivo Capital, LLC | 3,400,261 | $150,598,000 | 16.63% |
| Nan Fung Group Holdings Ltd | 510,978 | $22,631,000 | 14.44% |
| venBio Partners LLC | 1,125,673 | $49,856,000 | 11.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $11,715,000 | 3.76% |
| ASHFORD CAPITAL MANAGEMENT INC | 490,768 | $21,736,000 | 3.32% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,485 | $28,190,000 | 2.79% |
| Octagon Capital Advisors LP | 243,500 | $10,785,000 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 310,000 | $13,730,000 | 1.68% |
| Lisanti Capital Growth, LLC | 248,070 | $10,987,000 | 1.47% |